Kim, Kyoung Lae
Kim, Hyerim
Lee, Youngju
Lee, Cheolju
Joo, Kwangsic
Park, Sang Jun
Park, Kyu Hyung
Park, Seong-Jun
Woo, Se Joon
Funding for this research was provided by:
National Research Foundation of Korea (2017M3C9A5031595, 2020R1F1A1072795)
Article History
Received: 26 August 2021
Accepted: 21 September 2022
First Online: 15 November 2022
Competing interests
: Se Joon Woo: Samsung Bioepis (C, S), Curacle (C, S), Alteogen (C, S), Novelty Nobility (C, S), Panolos Bioscience (C, O), Novartis (C, L, S), Janssen (C), Bayer (L), Allergan (C, L), Abbvie (L, S), Alcon (L), SCAI Therapeutics (L), Philophos (C), Retimark (O) (C: consultant; L: Lecture fee; O: Equity Owner; S: grant support. All other authors have no competing/conflict of interest.